Name: Prostacor (30 Day Supply)
Brand: Nutreance

Saw Palmetto

The [prostate] inflammatory hypothesis was tested in humans. Our pilot study shows a significant reduction of some inflammatory parameters in prostatic tissues of patients treated with [saw palmetto]. These biological findings justify a pharmacological effect [...] on the inflammatory status of the adenoma. A correlation with clinical improvement was observed.
Read the Abstract
Vela Navarrete R, Garcia Cardoso JV, Barat A, Manzarbeitia F, López Farré A. Eur Urol. 2003 Nov;44(5):549-55.

Paubert-Braquet M, Mencia Huerta JM, Cousse H, Braquet P. Prostaglandins Leukot Essent Fatty Acids. 1997 Sep;57(3):299-304.

Read the Abstract

Breu W, Hagenlocher M, Redl K, Tittel G, Stadler F, Wagner H. Arzneimittelforschung. 1992 Apr;42(4):547-51.

Read the Abstract

Iehlé C, Délos S, Guirou O, Tate R, Raynaud JP, Martin PM. J Steroid Biochem Mol Biol. 1995 Sep;54(5-6):273-9.

Read the Abstract

Weisser H, Tunn S, Behnke B, Krieg M. Prostate. 1996 May;28(5):300-6.

Read the Abstract

Palin MF, Faguy M, LeHoux JG, Pelletier G. Endocrine. 1998 Aug;9(1):65-9.

Read the Abstract

Beta-Sitosterol

38 patients who continued beta-sitosterol treatment had stable values for all outcome variables between the end of the double-blind study and after 18 months of follow-up. The 41 patients choosing no further therapy had slightly worse symptom scores and PVR, but no changes in Qmax. Of the former placebo group, 27 patients who started beta-sitosterol after the double-blind trial improved to the same extent as the treated group for all outcome variables. The 18 patients choosing no further therapy showed no signs of improvement.
Read the Abstract
Berges RR, Kassen A, Senge T. BJU Int. 2000 May;85(7):842-6.

Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. Cochrane Database Syst Rev. 2000;(2):CD001043.

Read the Abstract

Berges RR, Windeler J, Trampisch HJ, Senge T. Lancet. 1995 Jun 17;345(8964):1529-32.

Read the Abstract

Klippel KF, Hiltl DM, Schipp B. Br J Urol. 1997 Sep;80(3):427-32.

Read the Abstract

Wilt TJ, MacDonald R, Ishani A. BJU Int. 1999 Jun;83(9):976-83.

Read the Abstract

Stinging Nettle

One group was given nettle and other group placebo [...] similarly and consistently for a period of 8 weeks. [...] No side effects were reported by the patients in the end of the study. According to the results, nettle had a better effect in relieving clinical symptoms in [...] patients compared to placebo.
Read the Abstract
Ghorbanibirgani A, Khalili A, Zamani L. Iran Red Crescent Med J. 2013 Jan;15(1):9-10. doi: 10.5812/ircmj.2386. Epub 2013 Jan 5.

Nahata A, Dixit VK. Andrologia. 2012 May;44 Suppl 1:396-409. doi: 10.1111/j.1439-0272.2011.01197.x. Epub 2011 Aug 2.

Read the Abstract

Hirano T, Homma M, Oka K. Planta Med. 1994 Feb;60(1):30-3.

Read the Abstract

Schneider T, Rübben H. Urologe A. 2004 Mar;43(3):302-6.

Read the Abstract

Safarinejad MR. J Herb Pharmacother. 2005;5(4):1-11.

Read the Abstract

Pumpkin Seed

A total of 1,431 men (50-80 years) with [enlarged prostates] were randomly assigned to either pumpkin seed, [...] capsules with pumpkin seed extract [...] or matching placebo. [...] In the case of pumpkin seed [...], the difference compared with placebo [...] was descriptively significant. The study products were well tolerated. Overall, [...] 12 months of treatment with pumpkin seed led to a clinically relevant reduction in IPSS [(International Prostate Symptom Score)] compared with placebo.
Read the Abstract
Vahlensieck W, Theurer C, Pfitzer E, Patz B, Banik N, Engelmann U. Urol Int. 2015;94(3):286-95. doi: 10.1159/000362903. Epub 2014 Sep 5.

Gossell-Williams M, Davis A, O'Connor N. J Med Food. 2006 Summer;9(2):284-6.

Read the Abstract

Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, Santos PB, Stonebrook KA, deKernion JB. J Urol. 2000 May;163(5):1451-6.

Read the Abstract

Tsai YS, Tong YC, Cheng JT, Lee CH, Yang FS, Lee HY. Urol Int. 2006;77(3):269-74.

Read the Abstract

Carbin BE, Larsson B, Lindahl O. Br J Urol. 1990 Dec;66(6):639-41.

Read the Abstract

Lycopene

The results show that lycopene significantly inhibited the growth of [normal human prostate epithelial cells] in a dose-dependent fashion. Flow cytometry revealed a significant cell cycle arrest in the G0/G1 phase. This effect was confirmed by inhibition of cyclin D1 protein expression, whereas cyclin E levels remained unchanged. The results demonstrate that lycopene inhibits growth of nonneoplastic [normal human prostate epithelial cells] in vitro. [...] This might have an effect on prostate development and/or on enlargement of prostate tissue.
Read the Abstract
Obermüller-Jevic UC, Olano-Martin E, Corbacho AM, Eiserich JP, van der Vliet A, Valacchi G, Cross CE, Packer L. J Nutr. 2003 Nov;133(11):3356-60.

Schwarz S1, Obermüller-Jevic UC, Hellmis E, Koch W, Jacobi G, Biesalski HK. J Nutr. 2008 Jan;138(1):49-53.

Read the Abstract

Wertz K. Nutr Cancer. 2009;61(6):775-83. doi: 10.1080/01635580903285023.

Read the Abstract

Zou Y, Aboshora W, Li J, Xiao T, Zhang L. Phytother Res. 2017 Aug;31(8):1192-1198. doi: 10.1002/ptr.5838. Epub 2017 Jun 20.

Read the Abstract

Minutoli L, Bitto A, Squadrito F, Marini H, Irrera N, Morgia G, Passantino A, Altavilla D. Curr Med Chem. 2013;20(10):1306-12.

Read the Abstract

Wertz K, Siler U, Goralczyk R. Arch Biochem Biophys. 2004 Oct 1;430(1):127-34.

Read the Abstract